To estimate the significance of PKC signaling for RIPK4 activity in WM266.4 cells and its consequences for cell motility, we treated melanoma cells with 150 nM phorbol-12-myristate-13-acetate (PMA). This evidence concerns the gene PRRT2 and melanoma.